COLLEGIUM PHARMACEUTICAL, INC business relationships
Companies named in COLLEGIUM PHARMACEUTICAL, INC’s 10-K filed 2026-02-26, and public companies whose annual reports name COLLEGIUM PHARMACEUTICAL, INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.2 / 10
- AI naming
- 46 / 100 Top 1% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in COLLEGIUM PHARMACEUTICAL, INC’s annual report 4
“License Agreement (U.S.), dated as of January 13, 2015, by and among Grünenthal GmbH, Janssen Research & Development, LLC, Assertio Therapeutics, Inc. and Collegium Pharmaceutical, Inc.” SEC filing
“Exclusive License Agreement, dated April 4, 2019, between the Company and Shionogi, Inc. (incorporated by reference to Exhibit 10.19 to the Annual Report on Form 10-K filed by BDSI on March 9, 2022).” SEC filing
“Xtampza ER is manufactured in a dedicated suite at a site operated by our contract manufacturing organization, Patheon, part of Thermo Fisher Scientific.” SEC filing
“Jornay PM drug product is manufactured by Coating Place Inc, in Verona, Wisconsin.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.